SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (2025)

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (1) https://doi.org/10.1158/1078-0432.ccr-09-1247 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (2) Full text

Journal: Clinical Cancer Research, 2010, №1, p.260-268

Publisher: American Association for Cancer Research (AACR)

Authors: Zhong-Sheng Zhao, Yuan-Yu Wang, Yong-Quan Chu, Zai-Yuan Ye, Hou-Quan Tao

Abstract

Abstract Purpose: The present study investigated the clinical significance of secreted protein, acidic and rich in cysteine (SPARC), in the development and progression of gastric cancer. Experimental Design: Immunohistochemistry was used to analyze SPARC, integrin β1, and matrix metalloproteinase (MMP)-2 expression in 436 clinicopathologically characterized gastric cancer cases. Results: SPARC, integrin β1, and MMP-2 protein levels were upregulated in gastric cancer lesions compared with adjacent noncancerous tissues. SPARC protein was detected in 334 of 436 human gastric cancer cases and was highly expressed in 239 tumors. We also found a positive correlation between expression of SPARC and MMP2, and SPARC and integrin β1. In stages I, II, and III, the 5-year survival rate of patients with a high expression of SPARC was significantly lower than those in patients with low expression. In stage IV, SPARC expression did not correlate with the 5-year survival rate. Further multivariate analysis suggested that the depth of invasion; lymph node and distant metastasis; tumor-node-metastasis stage; and upregulation of SPARC, MMP-2, and integrin β1, were independent prognostic indicators for the disease. Conclusions: Our study provided a basis for the development of a novel biomarker for diagnosis and prognosis of gastric cancer. Expression of SPARC in gastric cancer is significantly associated with lymph node and distant metastasis, high MMP2 expression, high intergrin β1 expression, and poor prognosis. SPARC, intergrin β1, and MMP-2 protein could be useful markers to predict tumor progression. Clin Cancer Res; 16(1); 260–8

List of references

  1. Inoue, Epidemiology of gastric cancer in Japan, Postgrad Med J, № 81, с. 419
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (3) https://doi.org/10.1136/pgmj.2004.029330
  2. Zhan, Surgical therapy of gastric cancer in china, J Pract Oncol, № 23, с. 91
  3. Ajani, Evolving chemotherapy for advanced gastric cancer, Oncologist, № 10, с. 49
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (4) https://doi.org/10.1634/theoncologist.10-90003-49
  4. Qi, SPARC, a matricellular glycoprotein with important biological functions, J Histochem Cytochem, № 47, с. 1495
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (5) https://doi.org/10.1177/002215549904701201
  5. Bornstein, Matricellular proteins: extracellular modulators of cell function, Curr Opin Cell Biol, № 14, с. 608
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (6) https://doi.org/10.1016/S0955-0674(02)00361-7
  6. Menon, A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin, Int J Oncol, № 17, с. 683
  7. Iacobuzio-Donahue, The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types, Cancer Res, № 62, с. 5351
  8. Yamashita, Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression, Cancer, № 97, с. 2412
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (7) https://doi.org/10.1002/cncr.11368
  9. Thomas, Differential expression of osteonectin/SPARC during human prostate cancer progression, Clin Cancer Res, № 6, с. 1140
  10. Yamanaka, Analysis of the gene expression of SPARC and its prognostic value for bladder cancer, J Urol, № 166, с. 2495
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (8) https://doi.org/10.1016/S0022-5347(05)65623-6
  11. Takano, Gene expression profiles in thyroid carcinomas, Br J Cancer, № 83, с. 1495
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (9) https://doi.org/10.1054/bjoc.2000.1483
  12. Maeng, Osteonectin-expressing cells in human stomach cancer and their possible clinical significance, Cancer Lett, № 184, с. 117
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (10) https://doi.org/10.1016/S0304-3835(02)00191-X
  13. Wang, Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance, Br J Cancer, № 91, с. 1924
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (11) https://doi.org/10.1038/sj.bjc.6602213
  14. Brekken, SPARC, a matricellular protein: at the crossroads of cell-matrix communication, Matrix Biol, № 19, с. 816
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (12) https://doi.org/10.1016/S0945-053X(00)00133-5
  15. Lane, The biology of SPARC, a protein that modulates cell-matrix interactions, FASEB J, № 8, с. 163
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (13) https://doi.org/10.1096/fasebj.8.2.8119487
  16. McClung, SPARC up-regulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells, Neurosci Lett, № 419, с. 172
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (14) https://doi.org/10.1016/j.neulet.2007.04.037
  17. Weaver, The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin β1 and activation of integrin-linked kinase, J Biol Chem, № 283, с. 22826
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (15) https://doi.org/10.1074/jbc.M706563200
  18. Lee, Tumour suppressor gene expression correlates with gastric cancer prognosis, J Pathol, № 200, с. 39
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (16) https://doi.org/10.1002/path.1288
  19. Lee, MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators, Cancer, № 92, с. 1427
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (17) https://doi.org/10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L
  20. Zhang, Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer, Mod Pathol, № 16, с. 79
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (18) https://doi.org/10.1097/01.MP.0000047307.96344.93
  21. Lee, Protein expression profiling and molecular classification of gastric cancer by the tissue array method, Clin Cancer Res, № 13, с. 4154
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (19) https://doi.org/10.1158/1078-0432.CCR-07-0173
  22. Kolev, Prognostic significance of VEGF expression in correlation with COX-2, microvessel density and clinicopathological characteristics in human gastric carcinoma, Ann Surg Oncol, № 14, с. 2738
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (20) https://doi.org/10.1245/s10434-007-9484-7
  23. Mizokami, Clinicopathologic significance of hypoxia-inducible factor 1 α overexpression in gastric carcinomas, J Surg Oncol, № 94, с. 149
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (21) https://doi.org/10.1002/jso.20568
  24. Song, The clinical significance of twist expression in nasopharyngeal carcinoma, Cancer Lett, № 242, с. 258
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (22) https://doi.org/10.1016/j.canlet.2005.11.013
  25. Geisler, p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer, Clin Cancer Res, № 8, с. 3445
  26. Fukuoka, Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer, Clin Cancer Res, № 10, с. 4314
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (23) https://doi.org/10.1158/1078-0432.CCR-03-0489
  27. Framson, SPARC and tumor growth: where the seed meets the soil?, J Cell Biochem, № 92, с. 679
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (24) https://doi.org/10.1002/jcb.20091
  28. Podhajcer, The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host, Cancer Metastasis Rev, № 27, с. 523
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (25) https://doi.org/10.1007/s10555-008-9135-x
  29. Watkins, Increased levels of SPARC(osteonectin) in human breast cancer tissues and its association with clinical outcomes, Prostaglandins Leukot Essent Fatty Acids, № 72, с. 267
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (26) https://doi.org/10.1016/j.plefa.2004.12.003
  30. Infante, Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma, J Clin Oncol, № 25, с. 319
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (27) https://doi.org/10.1200/JCO.2006.07.8824
  31. He, Expression of peroxisome proliferator-activated receptor γ, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases, Chin Med J Engl, № 120, с. 1498
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (28) https://doi.org/10.1097/00029330-200709010-00007
  32. Wang, Changes of histology and expression of MMP-2 and nm23-1 in primary and metastatic gastric cancer, World J Gastroenterol, № 14, с. 1612
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (29) https://doi.org/10.3748/wjg.14.1612
  33. Mönig, Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma, Histopathology, № 39, с. 597
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (30) https://doi.org/10.1046/j.1365-2559.2001.01306.x
  34. Zheng, Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma, Anticancer Res, № 26, с. 3579
  35. Alakus, Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer, Histol Histopathol, № 23, с. 917
  36. Matsuoka, Increased expression of α2β1-integrin in the peritoneal dissemination of human gastric carcinoma, Int J Mol Med, № 5, с. 21
  37. Yoshimasu, Increased expression of integrin α3β1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line, Cancer Sci, № 95, с. 142
    SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (31) https://doi.org/10.1111/j.1349-7006.2004.tb03195.x

Publications that cite this publication

GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs

Qingzhi Ji, Huimin Zhu, Yuting Qin, Ruiya Zhang, Lei Wang, Erhao Zhang, Xiaorong Zhou, Run Meng

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (32) https://doi.org/10.3389/fphar.2024.1329636 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (33)

2024, Frontiers in Pharmacology

Scopus

WoS

Crossref citations:0

Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway

Yixuan Sun, Yuzhen Qian, Chunxia Chen, Hongfei Wang, Xiuman Zhou, Wenjie Zhai, Lu Qiu, Xiaowen Zhou, Haoming Ning, Yumiao Zhao, Chao Shi, Lu Han, Yuanming Qi, Yahong Wu, Yanfeng Gao

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (34) https://doi.org/10.1186/s13046-022-02348-8 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (35)

2022, Journal of Experimental &amp; Clinical Cancer Research, №1

Scopus

WoS

Crossref citations:0

Correlation between SPARC (Osteonectin) expression with immunophenotypical and invasion characteristics of pituitary adenomas

Mustafa Onoz, Recep Basaran, Berrin Gucluer, Nejat Isik, Tuncay Kaner, Aydin Sav, Ilhan Elmaci

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (36) https://doi.org/10.1111/apm.12342

2014, APMIS, №3, p.199-204

Scopus

WoS

Crossref citations:3

Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer

Wei-hua Zhou, Fang Tang, Jie Xu, Xing Wu, Zhi-ying Feng, Hai-gang Li, Dong-jun Lin, Chun-kui Shao, Quentin Liu

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (37) https://doi.org/10.1186/1471-2407-11-397 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (38) Full text

2011, BMC Cancer, №1

Scopus

WoS

Crossref citations:19

Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis

Hai-Yun Wang, Yang-Yang Li, Qiong Shao, Jing-Hui Hou, Fang Wang, Man-Bo Cai, Yi-Xin Zeng, Jian-Yong Shao

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (39) https://doi.org/10.1186/1479-5876-10-27 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (40) Full text

2012, Journal of Translational Medicine, №1

Scopus

WoS

Crossref citations:13

Up-regulation of long noncoding RNA M26317 correlates with tumor progression and poor prognosis in gastric cancer

Li Li, Yuan-Yu Wang, Xiao Zhou Mou, Zai-Yuan Ye, Zhong-Sheng Zhao

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (41) https://doi.org/10.1016/j.humpath.2018.04.008

2018, Human Pathology, p.44-53

Scopus

WoS

Crossref citations:10

High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer

Masao Nakajima, Shigefumi Yoshino, Shinsuke Kanekiyo, Noriko Maeda, Kazuhiko Sakamoto, Ryoichi Tsunedomi, Nobuaki Suzuki, Shigeru Takeda, Shigeru Yamamoto, Shoichi Hazama, Yoshinobu Hoshii, Atsunori Oga, Hiroshi Itoh, Tomio Ueno, Hiroaki Nagano

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (42) https://doi.org/10.3892/ol.2017.7418 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (43) Full text

2017, Oncology Letters

Scopus

WoS

Crossref citations:4

GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC

Baocheng Gong, Yuan Li, Zhenguo Cheng, Pengliang Wang, Lei Luo, Hanwei Huang, Shijie Duan, Funan Liu

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (44) https://doi.org/10.1177/1010428317704364 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (45) Full text

2017, Tumor Biology, №6, p.101042831770436

Scopus

Crossref citations:12

A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG

Hui Shi, Jiangling Duan, Zhangming Chen, Mengqi Huang, Wenxiu Han, Rui Kong, Xiuyin Guan, Zhen Qi, Shuang Zheng, Ming Lu

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (46) https://doi.org/10.1007/s12094-022-03003-6

2022, Clinical and Translational Oncology, №4, p.995-1010

WoS

Crossref citations:2

An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence

T Winder, P M Wilson, D Yang, W Zhang, Y Ning, D G Power, P Bohanes, A Gerger, L H Tang, M Shah, H-J Lenz

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (47) https://doi.org/10.1038/tpj.2012.11 · SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (48) Full text

2012, The Pharmacogenomics Journal, №4, p.342-348

Scopus

WoS

Crossref citations:5

Find all citations of the publication

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients (2025)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Terence Hammes MD

Last Updated:

Views: 6363

Rating: 4.9 / 5 (49 voted)

Reviews: 88% of readers found this page helpful

Author information

Name: Terence Hammes MD

Birthday: 1992-04-11

Address: Suite 408 9446 Mercy Mews, West Roxie, CT 04904

Phone: +50312511349175

Job: Product Consulting Liaison

Hobby: Jogging, Motor sports, Nordic skating, Jigsaw puzzles, Bird watching, Nordic skating, Sculpting

Introduction: My name is Terence Hammes MD, I am a inexpensive, energetic, jolly, faithful, cheerful, proud, rich person who loves writing and wants to share my knowledge and understanding with you.